144 related articles for article (PubMed ID: 27250606)
1. [Treatment of 14 cases of Castlemans disease: the experience of one centre and an overview of literature].
Adam Z; Szturz P; Krejčí M; Koukalová R; Michalková E; Řehák Z; Pourová E; Pour L; Volfová P; Sandecká V; Čermáková Z; Křen L; Sokol F; Hanke I; Penka I; Petrášová H; Ševčíková S; Král Z; Mayer J
Vnitr Lek; 2016 Apr; 62(4):287-98. PubMed ID: 27250606
[TBL] [Abstract][Full Text] [Related]
2. [PET-CT documented fast onset of treatment response to cyclophosphamide, thalidomide and dexamethasone in patients with multicentric Castlemans disease. Case description and treatment information overview].
Adam Z; Szturz P; Křen L; Krejčí M; Pour L; Svoboda T; Hanke I; Penka I; Koukalová R; Rehák Z; Cervinková I; Storková T; Král Z; Mayer J
Vnitr Lek; 2013 Apr; 59(4):301-12. PubMed ID: 23711057
[TBL] [Abstract][Full Text] [Related]
3. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
[TBL] [Abstract][Full Text] [Related]
4. [PET-CT documented remission of multicentric Castleman disease after treatment with rituximab: case report and review].
Adam Z; Szturz P; Koukalová R; Řehák Z; Pour L; Krejčí M; Šmardová L; Eid M; Volfová P; Čermáková Z; Křen L; Sokol F; Hanke I; Michalková E; Král Z; Mayer J
Vnitr Lek; 2015 Mar; 61(3):251-9. PubMed ID: 25873122
[TBL] [Abstract][Full Text] [Related]
5. [Castleman disease: retrospective single-center study of therapeutic results in 10 patients].
Szturz P; Adam Z; Rehák Z; Koukalová R; Sprláková-Puková A; Michalka J; Smardová L; Volfová P; Lengerová M; Mayer J
Klin Onkol; 2013; 26(2):124-34. PubMed ID: 23718671
[TBL] [Abstract][Full Text] [Related]
6. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
[TBL] [Abstract][Full Text] [Related]
7. Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient.
Law AB; Ryan G; Lade S; Prince HM
Int J Hematol; 2010 Mar; 91(2):347-8; author reply 349. PubMed ID: 20146033
[No Abstract] [Full Text] [Related]
8. Brief communication: rituximab in HIV-associated multicentric Castleman disease.
Bower M; Powles T; Williams S; Davis TN; Atkins M; Montoto S; Orkin C; Webb A; Fisher M; Nelson M; Gazzard B; Stebbing J; Kelleher P
Ann Intern Med; 2007 Dec; 147(12):836-9. PubMed ID: 18087054
[TBL] [Abstract][Full Text] [Related]
9. [Our experience in treatment of multicentric plasma-cell Castleman disease associated with vasculitis manifestations - case report and literature review].
Szturz P; Adam Z; Moulis M; Smardová L; Klincová M; Slaisová R; Koukalová R; Rehák Z; Volfová P; Chovancová J; Stehlíková O; Mayer J
Vnitr Lek; 2012 Sep; 58(9):679-90. PubMed ID: 23094815
[TBL] [Abstract][Full Text] [Related]
10. Unicentric Castlemans disease. Symptoms, diagnostics and therapy.
Adam Z; Řehák Z; Adamová Z; Koukalová R; Pour L; Krejčí M; Boichuk I; Krejčí M; Štork M; Ševčíková S; Král Z
Vnitr Lek; 2021; 67(8):465-473. PubMed ID: 35459366
[TBL] [Abstract][Full Text] [Related]
11. Therapy of Castleman's disease with siltuximab - case report and review of literature.
Adam Z; Zeman D; Chodacki A; Pour L; Horváth T; Benda P; Adamová Z; Krejčí M; Tomíška M; Boichuk I; Král Z
Klin Onkol; 2023; 37(4):320-329. PubMed ID: 38195387
[TBL] [Abstract][Full Text] [Related]
12. Severe warm-antibody autoimmune hemolytic anemia due to multicentric Castleman disease: Responding to rituximab.
Iskandar A; Hwang A; Dasanu CA
J Oncol Pharm Pract; 2019 Dec; 25(8):2016-2018. PubMed ID: 30486744
[TBL] [Abstract][Full Text] [Related]
13. A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab.
Plano F; Mancuso S; Camarda GM; Butera MG; Sucato G; Alecci G; Florena AM; Perrone S; Siragusa SM
Chemotherapy; 2024; 69(1):35-39. PubMed ID: 37634492
[TBL] [Abstract][Full Text] [Related]
14. Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease.
Fragasso A; Mannarella C; Ciancio A; Calvario A; Scarasciulli ML
Leuk Lymphoma; 2008 Nov; 49(11):2224-6. PubMed ID: 19021070
[No Abstract] [Full Text] [Related]
15. Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.
Zhou X; Wei J; Lou Y; Xu G; Yang M; Liu H; Mao L; Tong H; Jin J
Front Med; 2017 Jun; 11(2):287-292. PubMed ID: 28367597
[TBL] [Abstract][Full Text] [Related]
16. [Castlemans disease].
Majerčáková D
Vnitr Lek; 2012 Mar; 58(3):216-20. PubMed ID: 22486288
[TBL] [Abstract][Full Text] [Related]
17. Treatment of unicentric Castleman disease with neoadjuvant rituximab.
Bandera B; Ainsworth C; Shikle J; Rupard E; Roach M
Chest; 2010 Nov; 138(5):1239-41. PubMed ID: 21051400
[TBL] [Abstract][Full Text] [Related]
18. Castlemans disease - surgical treatment, case reports.
Penka I; Kala Z; Zetelová A; Kunovsky L; Szturz P; Kren L; Mechl M; Rehak Z; Hanke I
Rozhl Chir; 2016; 95(12):457-461. PubMed ID: 28182443
[TBL] [Abstract][Full Text] [Related]
19. [Idiopathic multicentric Castleman's disease].
Vasilyev VI; Palshina SG; Pavlovskaya AI; Kokosadze NV; Chaltsev BD; Shornikova LA
Ter Arkh; 2020 Jun; 92(5):78-84. PubMed ID: 32598779
[TBL] [Abstract][Full Text] [Related]
20. Sustained remission of severe Multicentric Castleman disease following multiagent chemotherapy and tocilizumab maintenance.
Turcotte LM; Correll CK; Reed RC; Moertel CL
Pediatr Blood Cancer; 2014 Apr; 61(4):737-9. PubMed ID: 24019247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
